ClinicalTrials.govpublic full text
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
pancreatic adenocarcinoma, stereotactic ablative body radiotherapy (sabr), durvalumab, 20-228, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877535
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.